Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helgo Magnussen

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Revue De Pneumologie Clinique|November 8, 2005
[Novolizer: what place among inhaled treatments?]Helgo Magnussen
Current Medical Research and Opinion|September 6, 2005
Novolizer: how does it fit into inhalation therapy?Helgo Magnussen
Deutsche Medizinische Wochenschrift (1946)|June 29, 2019
[Therapy control of COPD by Eosinophilic Granulocytes?]Helgo Magnussen
Current Opinion in Pulmonary Medicine|September 17, 2003
Inhalation therapy for bronchial asthma: strategies and targetsHelgo Magnussen
Medizinische Klinik (Munich, Germany : 1983)|January 21, 2006
[Prevalence of respiratory symptoms. Currently available data on German practices]Helgo Magnussen
Proceedings of the American Thoracic Society|December 17, 2009
Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbiditiesHelgo Magnussen, Henrik Watz
American Journal of Respiratory and Critical Care Medicine|July 28, 2009
Cutoff values for FENO-guided asthma managementOlaf Holz, Helgo Magnussen
COPD|July 3, 2019
Genuair<sup>®</sup>/Pressair<sup>®</sup> Inhaler in COPD: The Patient PerspectiveHelgo Magnussen, Beatrix Fyrnys, Roland Greguletz
Medizinische Klinik (Munich, Germany : 1983)|April 29, 2009
[Measurement of physical activity in patients with chronic obstructive pulmonary disease]Helgo Magnussen, Benjamin Waschki, Henrik Watz
The New England Journal of Medicine|April 30, 2010
Emphysema, airflow obstruction, and left ventricular fillingHenrik Watz, Benjamin Waschki, Helgo Magnussen
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Revue De Pneumologie Clinique|November 8, 2005
[Novolizer: what place among inhaled treatments?]Helgo Magnussen
Current Medical Research and Opinion|September 6, 2005
Novolizer: how does it fit into inhalation therapy?Helgo Magnussen
Deutsche Medizinische Wochenschrift (1946)|June 29, 2019
[Therapy control of COPD by Eosinophilic Granulocytes?]Helgo Magnussen
Current Opinion in Pulmonary Medicine|September 17, 2003
Inhalation therapy for bronchial asthma: strategies and targetsHelgo Magnussen
Medizinische Klinik (Munich, Germany : 1983)|January 21, 2006
[Prevalence of respiratory symptoms. Currently available data on German practices]Helgo Magnussen
Proceedings of the American Thoracic Society|December 17, 2009
Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbiditiesHelgo Magnussen, Henrik Watz
American Journal of Respiratory and Critical Care Medicine|July 28, 2009
Cutoff values for FENO-guided asthma managementOlaf Holz, Helgo Magnussen
COPD|July 3, 2019
Genuair<sup>®</sup>/Pressair<sup>®</sup> Inhaler in COPD: The Patient PerspectiveHelgo Magnussen, Beatrix Fyrnys, Roland Greguletz
Medizinische Klinik (Munich, Germany : 1983)|April 29, 2009
[Measurement of physical activity in patients with chronic obstructive pulmonary disease]Helgo Magnussen, Benjamin Waschki, Henrik Watz
The New England Journal of Medicine|April 30, 2010
Emphysema, airflow obstruction, and left ventricular fillingHenrik Watz, Benjamin Waschki, Helgo Magnussen
Pageof 13